Unlocking the Potential on Health Innovation

Dr. Stephen Pandol - President, FNDD

Dr. Stephen J. Pandol, MD, is a renowned expert in gastroenterology and pancreatology, currently serving as the Director of Basic and Translational Pancreas Research at Cedars-Sinai Medical Center. He holds professorships at Cedars-Sinai Medical Center, the David Geffen School of Medicine at UCLA, and Charles Drew University. As a founder of Avenzoar Pharmaceutics, Dr. Pandol is at the forefront of developing innovative treatments aimed at overcoming therapy resistance and metastasis, with a special focus on pancreatic cancer.

Dr. Pandol leads a prominent research group dedicated to unraveling the mechanisms behind various pancreatic disorders, including inflammatory diseases, diabetes, and cancer. His work is pivotal in advancing our understanding of these conditions and developing effective strategies for their treatment and prevention. With over 500 scientific publications to his name, including articles, book chapters, and reviews, Dr. Pandol is a prolific contributor to the field. His expertise is sought after globally, as he frequently lectures and leads symposia on his groundbreaking research and the development of mechanism-based cures.

In addition to his research and academic roles, Dr. Pandol is the Co-Leader of the United States Consortium on Chronic Pancreatitis, Diabetes, and Pancreatic Cancer, where he is instrumental in advancing diagnostic and treatment methodologies for chronic pancreatitis and the early detection of pancreatic cancer. He is a past president of the American Pancreatic Association and serves as an editor for Frontiers in Gastrointestinal Sciences. His previous editorial roles include serving as an associate editor for the American Journal of Physiology, Gastroenterology, and Hepatology. Dr. Pandol’s contributions continue to shape the future of pancreatic research and treatment worldwide.

Scroll to Top